This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Rc Biotechnologies, Inc.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Lezhi Zhang: Innovator in Antibody-Drug Conjugates
Introduction
Lezhi Zhang is a prominent inventor based in Shandong, China. He has made significant contributions to the field of biotechnologies, particularly in the development of antibody-drug conjugates. With a total of 2 patents, his work focuses on enhancing the efficacy of therapeutic agents through innovative compositions.
Latest Patents
Zhang's latest patents include "Covalent linkers in antibody-drug conjugates and methods of making and using the same." This invention provides novel and advantageous compositions featuring a linker capable of covalently coupling one or more free thiols of an antibody. The patent details the molecular structures, synthetic pathways, coupling mechanisms, and applications of these linkers as utilized in antibody-drug conjugates (ADCs).
Career Highlights
Lezhi Zhang is associated with Rc Biotechnologies, Inc., where he applies his expertise in biochemistry and molecular biology. His innovative approaches have positioned him as a key figure in the advancement of therapeutic technologies.
Collaborations
Zhang collaborates with notable colleagues, including Jianmin Fang and Hui Ye. Their combined efforts contribute to the ongoing research and development in the field of biotechnologies.
Conclusion
Lezhi Zhang's work in the realm of antibody-drug conjugates exemplifies the impact of innovative thinking in biotechnology. His patents and collaborations highlight the importance of advancing therapeutic methods for improved patient outcomes.